sbi-100 ophthalmic emulsion
·Code: SBI-100 OE
sbi-100 ophthalmic emulsion: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Skye Bioscience, Inc. (SKYE) | Phase 2 |
Clinical Trials (1)
A Phase 2, Double-Masked, Randomized, Placebo-Controlled, Dose-Response Study Assessing the Safety and Ocular Hypotensive Efficacy of Two Concentrations of SBI-100 Ophthalmic Emulsion in Patients With Elevated Intraocular Pressure
Frequently asked questions
Who is developing sbi-100 ophthalmic emulsion?
sbi-100 ophthalmic emulsion is being developed by Skye Bioscience, Inc..
How many clinical trials involve sbi-100 ophthalmic emulsion?
BioSniper tracks 1 clinical trial involving sbi-100 ophthalmic emulsion.
Get deeper analysis on sbi-100 ophthalmic emulsion
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis